Form 4: Lemaitre Vascular Inc. Executive David B. Roberts Reports Stock Transactions

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported multiple transactions involving the acquisition and disposal of company stock and dividend equivalent rights.

Summary

• David B. Roberts, a director and officer at Lemaitre Vascular Inc., filed a Form 4 detailing several transactions.
• On December 11, 2024, Mr. Roberts acquired 18 shares of common stock and 18 dividend equivalent rights, both at a price of $0, and disposed of 196 shares at $101 per share to cover tax obligations.
• On December 12, 2024, he acquired 11 shares of common stock and 11 dividend equivalent rights, both at a price of $0, and disposed of 197 shares at $100.28 per share twice, also to cover tax obligations.
• These transactions resulted in a net decrease of 371 shares of common stock held by Mr. Roberts, but an increase in dividend equivalent rights.
• The disposals were related to tax withholding obligations from the vesting of restricted stock units and performance stock units.

Sentiment

Score: 5

Explanation: The document is neutral, detailing routine stock transactions by an executive. There is no indication of positive or negative sentiment.

Industry Context

This is a routine filing for insider transactions and is common for executives who receive stock-based compensation.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions are typical for executives receiving stock-based compensation, where shares are often sold to cover tax obligations upon vesting.
• Similar filings can be seen across the medical device industry for companies like Medtronic, Boston Scientific, and Abbott.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.

Key Dates

Keywords

Lemaitre Vascular Inc, LMAT, Form 4, insider trading, stock transactions, David B. Roberts, dividend equivalent rights, restricted stock units, performance stock units, tax withholding